Possible Role of Lysine Demethylase 2A in the Pathophysiology of Psoriasis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Psoriasis is a common chronic inflammatory skin disease. The development of psoriasis is dependent on many intercellular events such as innate immunity and T cell-mediated inflammation. Furthermore, genetic factors are strongly implicated in the pathophysiology of psoriasis. Although a variety of susceptible genes are identified, it is likely that many important genes remain undisclosed. Objective: The aim of this study is to investigate the possible role of lysine demethylase 2A (KDM2A) in the pathophysiology of psoriasis. Methods: We examined the expression of KDM2A using a well established imiquimod-induced psoriasiform dermatitis model. Results: Immunohistochemistry analysis showed that expression of KDM2A was increased in imiquimod-induced psoriasiform dermatitis. Consistent with this result, KDM2A level was markedly increased in the epidermis of psoriatic patient. When keratinocytes were stimulated with TLR3 agonist poly(I:C), KDM2A was increased at both the mRNA and protein levels. Poly(I:C) increased the expression of psoriasis-related cytokines including tumor necrosis factor-α, interleukin-8, and CCL20, and KDM2A inhibitor daminozide enhanced the poly(I:C)-induced cytokine expression. Finally, topical co-application of imiquimod and daminozide exacerbated the imiquimod-induced psoriasiform dermatitis. Conclusion: Together, these results suggest that KDM2A is increased to negatively regulate the inflammatory reaction of epidermal keratinocytes in psoriasis.
Abstract
Background: Psoriasis is a common chronic inflammatory skin disease. The development of psoriasis is dependent on many intercellular events such as innate immunity and T cell-mediated inflammation. Furthermore, genetic factors are strongly implicated in the pathophysiology of psoriasis. Although a variety of susceptible genes are identified, it is likely that many important genes remain undisclosed. Objective: The aim of this study is to investigate the possible role of lysine demethylase 2A (KDM2A) in the pathophysiology of psoriasis. Methods: We examined the expression of KDM2A using a well established imiquimod-induced psoriasiform dermatitis model. Results: Immunohistochemistry analysis showed that expression of KDM2A was increased in imiquimod-induced psoriasiform dermatitis. Consistent with this result, KDM2A level was markedly increased in the epidermis of psoriatic patient. When keratinocytes were stimulated with TLR3 agonist poly(I:C), KDM2A was increased at both the mRNA and protein levels. Poly(I:C) increased the expression of psoriasis-related cytokines including tumor necrosis factor-α, interleukin-8, and CCL20, and KDM2A inhibitor daminozide enhanced the poly(I:C)-induced cytokine expression. Finally, topical co-application of imiquimod and daminozide exacerbated the imiquimod-induced psoriasiform dermatitis. Conclusion: Together, these results suggest that KDM2A is increased to negatively regulate the inflammatory reaction of epidermal keratinocytes in psoriasis.
참고문헌 (25)
- Bos JD, "Psoriasis : dysregulation of innate immunity", Br J Dermatol, 152, pp.1098~1107 (2005)
- Benhadou F, "Psoriasis: keratinocytes or immune cells- which is the trigger?", Dermatology, 235, pp.91~100 (2019)
- Hawkes JE, "Psoriasis pathogenesis and the development of novel targeted immune therapies", J Allergy Clin Immunol, 140, pp.645~653 (2017)
- Brembilla NC, "The IL-17 family of cytokines in psoriasis : IL-17A and beyond", Front Immunol, 9, pp.1682~ (2018)
- Lai Y, "The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury", Immunity, 37, pp.74~84 (2012)
- Chandran V, "The genetics of psoriasis and psoriatic arthritis", Clin Rev Allergy Immunol, 44, pp.149~156 (2013)
- Semprini S, "Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees", Hum Genet, 111, pp.310~313 (2002)
- Strange A, "A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1", Nat Genet, 42, pp.985~990 (2010)
- Xu WH, "Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell", Mol Cell Biochem, 456, pp.95~104 (2019)
- Lu DH, "Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition", Oncol Rep, 41, pp.917~927 (2019)
- van der Fits L, "Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23", IL-17 axis, 2009, pp.182, 5836~5845
- Beutner KR, "Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts", Antimicrob Agents Chemother, 42, pp.789~794 (1998)
- Huen AO, "Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma", Curr Opin Oncol, 26, pp.237~244 (2014)
- Wu JK, "Psoriasis induced by topical imiquimod", Australas J Dermatol, 45, pp.47~50 (2004)
- Marie Madsen, "Differential Effects of Digoxin on Imiquimod-Induced Psoriasis-Like Skin Inflammation on the Ear and Back", Annals of Dermatology, 30(4), pp.485~488 (2018), 대한피부과학회
- Prens EP, "IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors : relevance for psoriasis", J Invest Dermatol, 128, pp.932~938 (2008)
- Rose NR, "Plant growth regulator daminozide is a selective inhibitor of human KDM2", 7 histone demethylases, 2012, pp.55, 6639~6643
- Ilyin GP, "cDNA cloning and expression analysis of new members of the mammalian F-box protein family", Genomics, 67, pp.40~47 (2000)
- Chen JY, "Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1", Oncotarget, 7, pp.27689~27710 (2016)
- Li J, "Understanding histone H3 lysine 36 methylation and its deregulation in disease", Cell Mol Life Sci, 76, pp.2899~2916 (2019)
- Tanaka Y, "JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation", EMBO J, 29, pp.1510~1522 (2010)
- Dhar SS, "Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells", J Biol Chem, 289, pp.7483~7496 (2014)
- Chen JY, "Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer", Oncogenesis, 6, pp.e369~ (2017)
- Lu T, "Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaB", Proc Natl Acad Sci U S A, 106, pp.16339~16344 (2009)
- Lu T, "Regulation of NF-kappaB by NSD1", FBXL11-dependent reversible lysine methylation of p65, 2010, pp.107, 46~51